Cardiac amyloidosis: the need for early diagnosis.

Oerlemans, M I F J; Rutten, K H G; Minnema, M C; Raymakers, R A P; Asselbergs, F W; de Jonge, N

Oerlemans, M I F J; Rutten, K H G; Minnema, M C; Raymakers, R A P; Asselbergs, F W; de Jonge, N.

Afiliação

Oerlemans MIFJ; Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands. M.Oerlemans@umcutrecht.nl.
Rutten KHG; Department of Hematology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Minnema MC; Department of Hematology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Raymakers RAP; Department of Hematology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Asselbergs FW; Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands.
de Jonge N; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.

Neth Heart J ; 27(11): 525-536, 2019 Nov.

Article em En | MEDLINE | ID: mdl-31359320

Palavras-chave

Amyloidosis; Awareness; Diagnosis; HFpEF; Heart; Left ventricular hypertrophy; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Neth Heart J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google